Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by Tarbabyon Feb 05, 2024 10:28am

257 Views

Post# 35862909

XPDT to kill Cancer

XPDT is the future of cancer destruction.
Its very simple. Just allow the tumours to absorb the photo dynamic drug... Rutherrin in this case.
Then apply numerouse xrays or low level radiation. This triggers the drug to release O3 radical oxygen which kills the cancer cells.
There is no collateral damage so this treatment can be repeated several times if needed.
Full body radiation will destroy cancer cells wherever they may be in the body.
Simple and quick...and no side effects.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market